CRNX
NASDAQ · Pharmaceuticals
Crinetics Pharmaceuticals In
$35.38
-0.49 (-1.37%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-26.23%
1Y
+18.29%
YTD
-24.29%
Open$35.91
Previous Close$35.87
Day High$37.07
Day Low$35.28
52W High$57.99
52W Low$25.83
Volume—
Avg Volume1.06M
Market Cap3.78B
P/E Ratio—
EPS$-5.13
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.40
Below
SMA 200
$38.81
Below
RSI (14)
27.9
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+39.6% upside
Current
$35.38
$35.38
Target
$49.40
$49.40
$38.77
$49.40 avg
$74.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.63M | 7.34M | 1.14B |
| Net Income | -521,633,774 | -399,447,287 | 346.78M |
| Profit Margin | -6,046.2% | -5,743.9% | 30.3% |
| EBITDA | -574,954,885 | -464,738,484 | 475.78M |
| Free Cash Flow | — | — | 205.84M |
| Rev Growth | +17.5% | +17.5% | +24.5% |
| Debt/Equity | — | — | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,102.08 | +0.32% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $231.29 | +1.27% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $115.48 | +1.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $25.08 | -0.52% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $54.70 | +1.30% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $75.89 | -3.58% | 12.5 | 33.00B |